Ibáñez Moreno JA, Bacca González JM, Taborda Murillo A, Ospina Ospina S, Arias LF. [Renal involvement in monoclonal gammopathies].
Rev Esp Patol 2022;
55:4-11. [PMID:
34980439 DOI:
10.1016/j.patol.2021.06.002]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/04/2021] [Revised: 05/26/2021] [Accepted: 06/04/2021] [Indexed: 06/14/2023]
Abstract
INTRODUCTION
The kidney is one of the organs most frequently affected by disease processes which produce monoclonal immunoglobins, therefore renal morphological and immunopathological alterations should be clearly recognized.
OBJECTIVE
To describe the pathological features of renal involvement in monoclonal gammopathies.
MATERIAL AND METHODS
A descriptive, retrospective and cross-sectional study of renal biopsies studied in a single center during a period of 14 years was carried out.
RESULTS
102 cases were included, of which 53% were male patients and the median age was 62.5 years (range 34 - 79). 97% of the biopsies were from native kidneys. The most frequent histopathological diagnosis (31.4%) was myeloma kidney, with kappa being the light chain most frequently deposited (65.6% of cases). AL amyloidosis was the second most common (29.4%) where the lambda chain predominated in 86.6%, followed by light chain deposition disease (20.6%) with the predominance of the kappa chain in 66.6%.
CONCLUSIONS
The most frequent renal involvement due to monoclonal gammopathies was myeloma kidney with deposition of kappa light chains, followed by AL lambda amyloidosis; these diseases were found more frequently in patients over 50 years of age.
Collapse